Page last updated: 2024-08-23

cabergoline and Hypercoagulability

cabergoline has been researched along with Hypercoagulability in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Bruin, C; de Herder, WW; de Jong, FH; de Maat, MP; Feelders, RA; Hermus, AR; Hofland, LJ; Lamberts, SW; Leebeek, FW; Netea-Maier, RT; Pereira, AM; Rijken, DC; Romijn, JA; van der Lely, AJ; van der Pas, R; Zelissen, PM	1

Trials

1 trial(s) available for cabergoline and Hypercoagulability

Article	Year
The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:4 Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Factors; Cabergoline; Dopamine Agonists; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Ergolines; Fibrinolysis; Humans; Hydrocortisone; Ketoconazole; Male; Middle Aged; Pituitary ACTH Hypersecretion; Pituitary Hormones, Anterior; Remission Induction; Somatostatin; Thrombophilia; Young Adult	2012

Article

Year

The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.

The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:4

Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Factors; Cabergoline; Dopamine Agonists; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Ergolines; Fibrinolysis; Humans; Hydrocortisone; Ketoconazole; Male; Middle Aged; Pituitary ACTH Hypersecretion; Pituitary Hormones, Anterior; Remission Induction; Somatostatin; Thrombophilia; Young Adult

2012